Now Available!
MedAxiom Reports highlight the latest CV industry data, trends and analysis to help hospitals and practices thrive.
MedAxiom’s fifth annual survey report presents practical applications for programs to design and implement team-based care models. The report shows how advanced practice provider (APP) leadership roles are beginning to guide new team-based care delivery models, developed to solve challenges related to growing and increasingly complex patient populations, cardiology workforce shortages, and an increased need for effective care coordination.
MedAxiom’s 2024 Cardiovascular Provider Compensation and Production Survey includes data from the largest number of providers since its debut. The 2024 report reflects the post-pandemic changes to the provider market through shifting practice ownership models, provider compensation and production trends, and the growing importance of team-based care. “As cardiovascular leaders are faced with challenging questions about how to best deliver care in the future, an accurate map of the current cardiovascular ecosystem is indispensable,” said MedAxiom President and CEO Jerry Blackwell, MD, MBA, FACC.
This report includes the results from a MedAxiom survey to assess the utilization, impact and understanding of G2211 code implementation. The survey showed that healthcare providers have widely adopted G2211, indicating a general acceptance of the code and recognition of its value.
The Pediatric Echocardiography Survey provides valuable insights into the current landscape of pediatric echocardiography services. Addressing the identified challenges, such as staffing shortages, outdated equipment, quality assurance gaps and reimbursement issues, will be crucial for healthcare organizations to deliver high-quality and sustainable pediatric echocardiography services. Collaborative efforts among stakeholders, including healthcare administrators, echocardiography department leaders, imaging managers, and policymakers, will be essential to drive positive change and ensure optimal patient care.
The pool of data published in the fourth annual report provides insights into best practices in APPs’ leadership, production and compensation, forming recommendations within the framework of the team-based care model. This year’s report focuses on the APP workforce, liability and split-shared billing, with a special section on the expanded role of APPs in heart failure clinics.
MedAxiom’s 2023 Cardiovascular Provider Compensation and Production Survey includes data from the largest number of providers since its debut. In addition to insightful year-over-year comparisons, the 2023 report reflects the consistency of year-over-year data from 2021 to 2022, the importance of a robust pool of data to form the foundation of the report, and the application of data as a strategic planning tool. "This report is an incredibly valuable tool for leaders who can use the data to develop plans and budget sensibly for recognized market trends, provider recruitment and retention strategies,” noted Kevin Mair, MBA, MedAxiom’s vice president of Care Transformation Services.
The increased prevalence of atrial fibrillation has resulted in a rise in left atrial appendage occlusion (LAAO) procedures. As programs work to manage these highly valuable procedures many face common challenges with care coordination and patient follow-up. MedAxiom visited three programs that use HAWKEYE, an online solution introduced by Boston Scientific in 2020, to help with the facilitation of LAAO patient workflow. This report provides data and insights from program leaders and care coordinators who utilize HAWKEYE compared to those who do not.
Advanced practice providers (APPs) are crucial members of the cardiovascular care team and programs across the country are increasingly seeking out innovative strategies to ensure effective utilization. MedAxiom’s third annual Cardiovascular APP Compensation and Utilization Report, which includes data and insights from nearly 100 organizations, dives deeper into acute care APP deployment and electrophysiology APP team models. Discover best practices and strategies for advancing your care team.
MedAxiom’s 10th annual Cardiovascular Provider Compensation and Production Survey Report – the industry’s gold standard – arms cardiovascular leaders with the data and insights needed to navigate a rapidly changing environment.
Powered by MedAxcess – the cardiovascular industry’s leading proprietary database and business intelligence application – the report highlights compensation and production findings across cardiology, surgery, advanced practice providers and non-clinical compensation, and includes a special section on 10-year trends.
MedAxiom surveyed its membership community to gain insights on the current state of invasive cardiology services across the country. The results show 96% of respondents are facing challenges staffing their cardiac cath labs and 85% said these challenges are more difficult than before the pandemic. View the full results in this report that reveals current staffing constrictions are still a major concern for many although the U.S. is starting to move past the pandemic.
MedAxiom conducted a survey to gauge the impact of a critical iodinated contrast supply shortage on cardiovascular organizations with imaging and procedure labs. As supply chain challenges are exposed, this survey provides a better understanding of what the cardiovascular community is doing to pivot during this short-term problem. Results show that 97% of programs surveyed are aware of a potential shortage of iodinated contrast. Nearly 60% of respondents say supply chain manages their iodinated contrast inventory and/or ordering and more than 80% of programs have a mechanism or committee structure that could rapidly respond if the contrast shortage becomes prolonged.
While call pay data is frequently sought for benchmarking and decision-making purposes, call and call pay are sensitive topics and difficult to quantify and normalize. That is proven by the results included in this report from a recent Call Pay Survey, conducted by MedAxiom.
The second annual Cardiovascular Advanced Practice Provider (APP) Compensation and Utilization Report highlights APP profession changes and trends related to staffing and leadership, compensation and benefits, schedules, roles and responsibilities, and more. Explore best practices and use the report to benchmark and optimize your program’s APP utilization.
MedAxiom’s ninth annual Cardiovascular Provider Compensation and Production Survey Report – which unveils trends across cardiology, surgery, advanced practice providers and non-clinical compensation – reveals the true impact of the coronavirus pandemic on cardiovascular programs in 2020. In addition to highlighting comparisons between private and integrated models, the report features new panel size metrics for workforce planning. Use this essential strategic planning tool – designed by cardiology, for cardiology – to optimize your organization and transform cardiovascular care in 2022 and beyond.
Coronary computed tomography angiography (CCTA) is one of the most disruptive recent advances in the cardiovascular industry. In order to drive the transformation of cardiovascular care delivery, MedAxiom surveyed its membership to better understand where cardiovascular programs are in their journey of adopting CCTA as well as barriers to adoption. More than 90% of respondents describe CCTA as a valuable cardiovascular imaging modality today and 100% note CCTA as a valuable imaging modality for the future. Regarding CCTA-derived fractional flow reserve (FFRCT), 77% of respondents said FFRCT will have a clinical impact on patient management.
Although the benefits of cardiac rehab (CR) are well documented, only a fraction of eligible patients in the U.S. enroll in a program after a major cardiovascular event or diagnosis. This survey report reveals insights related to CR program offerings, completion rates, staffing, leadership, barriers and more.
Over the past decade the cardiovascular industry has seen a significant increase in structural heart (SH) procedure volumes. Due to the coordination needed to treat these complex patients, most organizations have developed a formalized SH program. However, many face challenges with the current state and seek insights, tools and resources to support continued growth. MedAxiom conducted a national survey to better understand the SH program landscape. Discover best practices and opportunities for achieving efficient patient throughput, clinical effectiveness, appropriate staffing and effective access.
Healthcare organizations face tremendous pressure to decrease expenses while improving quality of care. Although cardiovascular procedure labs have many resources for measuring quality of care, the industry is lacking best practice guidelines and standardization of metrics in terms of operational performance management. In Spring of 2021 MedAxiom interviewed 29 programs, representing more than 200 cardiovascular procedure labs across the U.S., to better understand where innovation opportunities exist in the market to support performance management. Access the report to see the full assessment and explore how to improve data analytics for your cardiovascular procedure labs.
National shifts in the healthcare industry, including a move toward value-based reimbursement and provider risk, along with new non-traditional provider competitors, has created an urgent need for transforming the care delivery model. On top of this COVID-19 has shifted organizational priorities and strategies, putting staffing and workforce development in the forefront. MedAxiom surveyed its membership in March 2021 to better understand hiring insights and workforce trends to help CV programs navigate unprecedented times. These survey results helped to shape a new offering – MedAxiom Talent Solutions. Cardiovascular Expertise. Delivered. – that connects healthcare organizations with seasoned cardiovascular experts backed by the entire MedAxiom team.
MedAxiom’s eighth annual Cardiovascular Provider Compensation and Production Survey contains comprehensive data and analysis for cardiovascular organizations facing a new normal amid effects of the COVID-19 pandemic. The data findings reveal important trends across cardiology, surgery, advanced practice providers and non-clinical compensation as many programs are reevaluating compensation models and the definition of work productivity.
In this first annual Cardiovascular Advanced Practice Provider (APP) Compensation and Utilization Report Ginger Biesbrock, SVP MedAxiom Consulting, outlines current trends in APP roles and responsibilities, productivity, staffing ratios, hours, compensation and much more.
MedAxiom recently surveyed its members to gain insight into the initial impact of COVID-19 on CV organizations across the country. While the situation continues to unfold, a MedAxiom report provides data and insight into how CV organizations have adjusted to a new normal and what actions programs need to take now to ensure viability.
The highly sought-after resource for cardiovascular and healthcare decision makers navigating the volume-to-value shift taking place in the industry. It features the latest data, trends, and analysis you can get only from MedAxiom.
Highlights Include:
Overall total cardiology compensation increased 3 percent year over year, reaching the second highest total since 2012
Electrophysiologists are once again the top earner
Heart failure cardiologist compensation ($441,845 per FTE), reported for the first time, is 10 percent lower than general non-invasive compensation
The income gap between physicians in private vs. integrated groups narrowed to 3.5 percent
There are more cardiologists age 61 and over than ever before (about 1 in 4)
The specificity of this data can’t be found anywhere else in the country. The report shows cardiology-specific compensation and production information drilled down to:
Plus, this exclusive report includes:
An exclusive, curated collection of cardiovascular healthcare news.
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.